SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-20-000018
Filing Date
2020-03-02
Accepted
2020-03-02 16:08:45
Documents
16
Period of Report
2020-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxq42019earnings.htm   iXBRL 8-K 47826
2 EXHIBIT 99.1 exhibit991-q42019earningsr.htm EX-99.1 190016
8 beigene.jpg GRAPHIC 11453
  Complete submission text file 0001651308-20-000018.txt   419969

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20200302.xsd EX-101.SCH 4434
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20200302_cal.xml EX-101.CAL 622
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20200302_def.xml EX-101.DEF 1472
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20200302_lab.xml EX-101.LAB 27192
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20200302_pre.xml EX-101.PRE 14088
13 EXTRACTED XBRL INSTANCE DOCUMENT a8-kxq42019earnings_htm.xml XML 4466
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 20676861
SIC: 2834 Pharmaceutical Preparations